Psychiatry AtlasMedication guide · United States

Antidepressant

Trazodone (Desyrel, Oleptro)

Generic name
trazodone hydrochloride
Brand names
Desyrel; Oleptro
Medication class
Antidepressant
Forms covered
Trazodone hydrochloride immediate-release tablets

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

  • trazodone can be confused with tramadol.
  • Desyrel can be confused with Seroquel. Desyrel is a historical US brand name for this medication.

FDA Boxed Warning

Trazodone hydrochloride immediate-release tablets.

Antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults. Monitor everyone taking trazodone for worsening symptoms or emerging suicidal thoughts, especially when treatment starts or the dose changes. This medicine is not approved for children.

Trazodone treats major depression in adults. It is also prescribed off-label for insomnia, which is not an FDA-approved indication for these tablets.

Desyrel (historical brand); Oleptro (historical brand).

What to expect: Antidepressant benefit can take two weeks or longer, while sleepiness may appear earlier.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Major depressive disorder — Adults. Pediatric efficacy is not established.Trazodone hydrochloride immediate-release tablets.

Other uses (off-label)

Off-label means a medicine is prescribed for a use, age group or form that is not included in its FDA approval.

  • Insomnia — Individually assessed adults. Off-label; not an FDA insomnia indication.Trazodone hydrochloride immediate-release tablets.

What should I expect?

Antidepressant benefit can take two weeks or longer, while sleepiness may appear earlier. Feeling sleepy after a dose does not establish that depression is improving.

For off-label insomnia treatment, agree on what benefit is being assessed and when to review it. Daytime sedation, dizziness or unclear benefit deserves follow-up rather than an unsupervised dose change.

How do I take it safely?

Take immediate-release tablets shortly after a meal or light snack. Swallow them whole, or divide the selected scored tablets along the score if directed; do not chew or crush them. Do not transfer these instructions to an extended-release product.

Have heart-rhythm risks reviewed, including known QT prolongation, previous arrhythmia, low potassium or magnesium and a slow symptomatic pulse. Avoid use during initial recovery after a heart attack and with untreated anatomically narrow eye angles.

Do not use with an MAO inhibitor; allow at least 14 days in either switching direction. Linezolid and intravenous methylene blue are also contraindicated combinations.

Review other serotonin medicines, alcohol, sedatives, blood-pressure medicines, blood thinners, aspirin and anti-inflammatory pain medicines. CYP3A4 inhibitors and other QT-prolonging drugs raise cardiac concerns; dose-adjustment language does not make every combination safe.

Monitor mood, blood pressure on standing, sedation, falls, bleeding and low-sodium symptoms. Discuss bipolar disorder, kidney or liver disease, and conditions that increase prolonged-erection risk. ECGs and electrolyte or blood tests depend on individual risk.

Reduce gradually after regular treatment. Take a missed scheduled dose when remembered unless the next is near, then skip; never double.

Discuss pregnancy and breastfeeding; trazodone enters milk and infant data are limited. Pediatric use is not established. Older adults are more vulnerable to falls and low sodium.

What side effects should I know about?

  • Drowsiness, dizziness, dry mouth, fatigue, constipation, blurred vision and nausea.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • FDA boxed warning: antidepressants increase the risk of suicidal thoughts and behaviors in children, adolescents and young adults in short-term studies. Monitor people of every age for worsening mood, unusual behavior or suicidal thinking, especially when starting treatment or changing doses. Seek immediate help if someone cannot stay safe.
  • New suicidal thoughts or a severe mood or behavior change needs immediate clinical contact; get emergency help if someone cannot stay safe.
  • Stop trazodone and get emergency care for an erection lasting more than four hours, whether painful or not. Delayed treatment can cause lasting harm.
  • Get urgent medical care for fever with confusion or agitation, heavy sweating, diarrhea and stiff or twitching muscles. This combination may be serotonin syndrome, a potentially life-threatening reaction.
  • Contact the prescriber promptly for unusually high energy, very little need for sleep or risky behavior; these can be signs of mania.
  • Fainting or palpitations may signal a dangerous heart rhythm. Significant bleeding, black stools, severe confusion or a painful red eye with vision changes needs urgent care.
  • Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.

What else should I know to stay safe?

  • Do not use with an MAOI; allow at least 14 days in either switching direction. Linezolid and intravenous methylene blue are contraindicated combinations. Avoid known QT prolongation, prior arrhythmias and other significant rhythm risks, initial heart-attack recovery, or untreated anatomically narrow eye angles.
  • Review serotonin medicines, alcohol, sedatives, blood-pressure drugs, blood thinners, aspirin and anti-inflammatory pain medicines. CYP3A4 inhibitors and other QT-prolonging drugs raise cardiac concerns; dose-adjustment language does not make every combination safe. Monitor mood, standing blood pressure, sedation, falls, bleeding and low-sodium symptoms; tests depend on risk.
  • Discuss bipolar disorder, kidney or liver disease and conditions that increase prolonged-erection risk. Reduce regular treatment gradually. Pregnancy and breastfeeding need an individual discussion; infant data are limited. Older adults are more susceptible to falls and low sodium, and pediatric use is not established.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • A medicine used for sleep still carries antidepressant and heart-rhythm precautions. A low bedtime dose is not a reason to skip interaction checks.
  • Dizziness on standing can combine with nighttime trips to the bathroom to increase fall risk. Report this effect rather than assuming it is unavoidable.
  • An erection lasting more than four hours is an emergency whether or not it hurts; prompt treatment can prevent lasting injury.

How does it work?

Trazodone changes how nerve cells communicate using serotonin, a chemical messenger. It slows serotonin’s return into cells and blocks some of the receptors that respond to it, while partly activating another receptor type. These actions are thought to contribute to its antidepressant effect, but their combined role in improving mood is not fully understood.

Explore medication science

How was this medicine developed?

The FDA approved Desyrel in 1981. Trazodone’s sedating effects later led to common off-label insomnia use, but the approval for these tablets remains adult major depression. Generic immediate-release products now carry the relevant instructions.

How do I say the name?

Trazodone: TRAZ-oh-done. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Trazodone: patient medicine information
  2. Trazodone: current prescribing information
  3. Trazodone: FDA approval history
  4. Trazodone: Package Insert / Prescribing Information / MOA
  5. Trazodone: FDA prescribing information
  6. Trazodone: DailyMed product labeling
  7. Silenor: prescribing information
  8. Trazodone: verified neutral parent, PubChem CID 5533
  9. What Is a Neurotransmitter? — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: How Neurotransmitters Work; Types of Neurotransmitters..

  10. ISMP List of Confused Drug Names
  11. Frequently Asked Questions about Labeling for Prescription Medicines | FDA
  12. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  13. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top